Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease
Authors:
- Gloria E. MeredithGMGloria E. Meredith
- 1 November 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 190 (1) , 145-156
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated miceGeneral Pharmacology: The Vascular System, 2002
- Changes in Astroglial GLT-1 Expression after Neural Transplantation or Stab WoundsExperimental Neurology, 2002
- Impaired Glutamate Clearance as a Consequence of Energy Failure Caused by MPP+ in Astrocytic CulturesToxicology and Applied Pharmacology, 1999
- Regional Deafferentiation Down‐Regulates Subtypes of Glutamate Transporter ProteinsJournal of Neurochemistry, 1995
- Exacerbation of NMDA, AMPA, and l‐Glutamate Excitotoxicity by the Succinate Dehydrogenase Inhibitor MalonateJournal of Neurochemistry, 1995
- Block of glutamate transporters potentiates postsynaptic excitationNeuron, 1994
- Glial contributions to excitatory neurotransmission in cultured hippocampal cellsNature, 1994
- Glutamate uptake from the synaptic cleft does not shape the decay of the non-NMDA component of the synaptic currentNeuron, 1993
- Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters.Journal of Histochemistry & Cytochemistry, 1992
- Characterization of antisera to glutamate and aspartate.Journal of Histochemistry & Cytochemistry, 1988